Caris Life Sciences, Inc. (CAI)

24.58 +0.54 (+2.25%) USD  |  NASDAQ  |  Sep 11, 14:13
More

Caris Life Sciences Cash from Operations (Annual) : 75.44M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 75.44M
December 31, 2024 -245.20M
Date Value
December 31, 2023 -276.10M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
CareDx, Inc. 42.03M
Myriad Genetics, Inc. 1.80M
BioRestorative Therapies, Inc. -10.79M
Natera, Inc. 215.30M
Exagen, Inc. -13.62M